Apimeds amends settlement agreement for board structure
Apimeds Pharmaceuticals US Inc. filed a first amendment to a confidential settlement agreement, removing a specific Board of Directors composition timeframe from the original contract.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day